Dongyang Group: Net profit in the first quarter of 2026 was 119 million yuan, a year-on-year decrease of 57.10%.

In the first quarter of 2026, Dongyanguang announced that its operating income was 4.249 billion yuan, an increase of 26.95% year-on-year. Net profit was 1.19 billion yuan, a decrease of 57.10% year-on-year. During the reporting period, the company confirmed the amortization of equity incentive expenses and the impact of changes in fair value of the equity of Dongyanguang Pharmaceutical and Lidun, which had a certain impact on the net profit attributable to the shareholders of the listed company. Excluding the above factors, the company's operating profit was 3.52 billion yuan, achieving a year-on-year growth of 22.50%.